VIROLOGICAL DETERMINANTS OF HCV PROTEASE INHIBITOR RESISTANCE IN REAL-WORLD PATIENTS WITH POOR INTERFERON RESPONSIVENESS

Abstract

The global impact of hepatitis B and hepatitis C has recently been recognized by the World Health Organization. The Fellowship will support a research program that will use new technologies to answer a number of important questions concerning the pathogenesis of viral hepatitis B and C, interferon treatment response for HCV, and antiviral drug resistance. The outcomes of the research will be timely, clinically relevant, and of great interest to the international community. The ultimate goal is to improve clinical outcomes for patients.

Related publications (2)

Aiming for cure in HBV and HDV infection

Joerg Petersen, Alexander J Thompson, Massimo Levrero

2016-10-01

Chronic hepatitis B virus (HBV) infection continues to be a major health burden worldwide. Currently available antiviral treatment..

Treating hepatitis C - what's new?

Alex J Thompson, Jacinta A Holmes

2015-12-01

Chronic hepatitis C infection causes cirrhosis, liver failure and hepatocellular carcinoma, and is the most common indication for ..